Kissei Pharmaceutical (OTCMKTS:KSPHF – Get Free Report) is expected to post its results after the market closes on Wednesday, November 4th. Analysts expect Kissei Pharmaceutical to post earnings of $0.3033 per share and revenue of $136.82 million for the quarter.
Kissei Pharmaceutical Stock Performance
KSPHF stock opened at $24.50 on Wednesday. Kissei Pharmaceutical has a twelve month low of $23.23 and a twelve month high of $31.90. The stock’s 50 day moving average is $25.29 and its 200-day moving average is $25.91.
Kissei Pharmaceutical Company Profile
Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacture and marketing of prescription medicines and related healthcare products. The company focuses primarily on therapeutic areas including urology, gastroenterology, nephrology, gynecology and metabolic disorders.
Kissei develops and commercializes medicines for conditions such as overactive bladder, urinary disorders and gastrointestinal diseases. Its activities include drug discovery, clinical development, manufacturing and the distribution of pharmaceutical products through Japan’s healthcare system.
Founded in 1946 and headquartered in Matsumoto, Nagano, Kissei Pharmaceutical serves the Japanese market and pursues international activities through overseas subsidiaries, licensing arrangements and partnerships.
Read More
- Five stocks we like better than Kissei Pharmaceutical
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
